Retinoic acid potentiates phorbol ester-mediated induction of urokinase and plasminogen activator inhibitor type 2 in human myeloid leukemic cell lines.
Schuster, W A
Retinoic acid potentiates phorbol ester-mediated induction of urokinase and plasminogen activator inhibitor type 2 in human myeloid leukemic cell lines. [electronic resource] - Endocrinology Oct 1993 - 1724-30 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0013-7227
10.1210/endo.133.4.8404615 doi
Drug Synergism
Enzyme Induction
Humans
Leukemia, Myeloid--metabolism
Plasminogen Activator Inhibitor 2--genetics
Plasminogen Activators--metabolism
RNA, Messenger--metabolism
Receptors, Cell Surface--drug effects
Receptors, Urokinase Plasminogen Activator
Templates, Genetic
Tetradecanoylphorbol Acetate--pharmacology
Tretinoin--pharmacology
Tumor Cells, Cultured
Urokinase-Type Plasminogen Activator--genetics
Retinoic acid potentiates phorbol ester-mediated induction of urokinase and plasminogen activator inhibitor type 2 in human myeloid leukemic cell lines. [electronic resource] - Endocrinology Oct 1993 - 1724-30 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0013-7227
10.1210/endo.133.4.8404615 doi
Drug Synergism
Enzyme Induction
Humans
Leukemia, Myeloid--metabolism
Plasminogen Activator Inhibitor 2--genetics
Plasminogen Activators--metabolism
RNA, Messenger--metabolism
Receptors, Cell Surface--drug effects
Receptors, Urokinase Plasminogen Activator
Templates, Genetic
Tetradecanoylphorbol Acetate--pharmacology
Tretinoin--pharmacology
Tumor Cells, Cultured
Urokinase-Type Plasminogen Activator--genetics